Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
[HTML][HTML] Current approaches for diagnosis of influenza virus infections in humans
Despite significant advancement in vaccine and virus research, influenza continues to be a
major public health concern. Each year in the United States of America, influenza viruses …
major public health concern. Each year in the United States of America, influenza viruses …
Current and emerging cell culture manufacturing technologies for influenza vaccines
E Milián, AA Kamen - BioMed research international, 2015 - Wiley Online Library
Annually, influenza virus infects millions of people worldwide. Vaccination programs against
seasonal influenza infections require the production of hundreds of million doses within a …
seasonal influenza infections require the production of hundreds of million doses within a …
[HTML][HTML] Adenoviral vector-based vaccine platforms for develo** the next generation of influenza vaccines
Ever since the discovery of vaccines, many deadly diseases have been contained
worldwide, ultimately culminating in the eradication of smallpox and polio, which …
worldwide, ultimately culminating in the eradication of smallpox and polio, which …
Adenoviral vector-based strategies against infectious disease and cancer
C Zhang, D Zhou - Human vaccines & immunotherapeutics, 2016 - Taylor & Francis
Adenoviral vectors are widely employed against infectious diseases or cancers, as they can
elicit specific antibody responses and T cell responses when they are armed with foreign …
elicit specific antibody responses and T cell responses when they are armed with foreign …
Adenovirus-based vaccines for fighting infectious diseases and cancer: progress in the field
Since the development of the first vaccine against smallpox over two centuries ago,
vaccination strategies have been at the forefront of significantly impacting the incidences of …
vaccination strategies have been at the forefront of significantly impacting the incidences of …
A recombinant bovine adenoviral mucosal vaccine expressing mycobacterial antigen-85B generates robust protection against tuberculosis in mice
Although the BCG vaccine offers partial protection, tuberculosis remains a leading cause of
infectious disease death, killing∼ 1.5 million people annually. We developed mucosal …
infectious disease death, killing∼ 1.5 million people annually. We developed mucosal …
Viral vector-based influenza vaccines
Antigenic drift of seasonal influenza viruses and the occasional introduction of influenza
viruses of novel subtypes into the human population complicate the timely production of …
viruses of novel subtypes into the human population complicate the timely production of …